Yajie Yin Selected Research

Messenger RNA (mRNA)

2/2021

Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yajie Yin Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 11/2017
11	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 09/2016
7	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2018
5	Obesity 01/2023 - 01/2018
2	Weight Loss (Weight Reduction) 01/2023 - 09/2016
2	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 11/2023
1	Infections 11/2023
1	Body Weight (Weight, Body) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021
1	Hypersensitivity (Allergy) 01/2020
1	Immediate Hypersensitivity 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Glioma (Gliomas) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Lactic Acidosis 11/2017

Drug/Important Bio-Agent (IBA)

6	TIC10 compoundIBA 01/2022 - 01/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2020
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 09/2016
3	ONC206IBA 01/2022 - 01/2020
3	Dopamine Receptors (Dopamine Receptor)IBA 02/2021 - 01/2020
3	BiguanidesIBA 01/2021 - 09/2016
2	Adenosine Triphosphate (ATP)IBA 08/2023 - 09/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2023 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 01/2021
2	LipidsIBA 02/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2017
1	Immunologic Factors (Immunomodulators)IBA 11/2023
1	RO 3306IBA 08/2023
1	AntigensIBA 01/2023
1	EnzymesIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2023
1	Orlistat (Xenical)FDA Link 01/2023
1	C-Reactive ProteinIBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	AutoantigensIBA 11/2021
1	Messenger RNA (mRNA)IBA 02/2021
1	Fish OilsIBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	cremophor ELIBA 01/2020
1	ProdrugsIBA 01/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Generic DrugsIBA 01/2019
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2018
1	IsoflavonesIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	IsoenzymesIBA 01/2018
1	Topiramate (Topamax)FDA LinkGeneric 01/2018
1	Estrogen Receptor alphaIBA 01/2018
1	Carbonic Anhydrase IXIBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	GenisteinIBA 01/2018
1	Phenformin (Fenformin)IBA 11/2017
1	Caspase 3 (Caspase-3)IBA 11/2017
1	Glutamine (L-Glutamine)FDA Link 09/2017
1	Aminooxyacetic AcidIBA 09/2017
1	Pyruvic Acid (Pyruvate)IBA 09/2017
1	Calcium Carbonate (Limestone)FDA Link 09/2016

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2020
3	Fat-Restricted Diet (Diet, Fat Restricted) 01/2023 - 02/2021
1	Immunotherapy 11/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2023